The overall goal of this competitive renewal is to identify pivotal mechanisms to regulate pulmonary macrophage gene expression that contribute to the molecular pathogenesis of lung inflammation in severe sepsis and are amenable to interdiction. Our published studies indicate that PU.1 is a critical regulator of mature macrophage function and that prophylactic conditional genetic ablation of PU.1 in mice greatly attenuates lung inflammation and permeability edema in response to endotoxemia. Our supportive data indicate that PU.1 regulates demethylation of Kr?ppel-like factor 4 (KLF4) which allows the engagement of PU.1 to the KLF4 enhancer region resulting in transcriptional KLF4 gene expression. Ectopic over-expression of KLF-4 results in prolongation of NF-kB activation in macrophages and accentuates the duration of neutrophilic lung inflammation in mice suggesting that the pro-inflammatory effects of PU.1 are transduced through KLF4. Furthermore, we have shown that KLF4 and KLF2 may have antagonistic effects on the expression of the pro vs. counter-inflammatory macrophage inflammatory phenotype. We therefore hypothesize that """"""""pulmonary macrophages regulate the resolution of lung inflammation through epigenetic and transcriptional regulation of KLF4 gene expression by PU.1"""""""". In two specific aims that focus on whole animal models of acute lung injury we will determine whether PU.1 induction of KLF4 contributes to the pro-inflammatory (M1) macrophage phenotype whereas deficiency or competitive inhibition of KLF4 by KLF2 results in a phenotypic shift to a counter-inflammatory (M2) phenotype that is involved in restoring lung health.
Specific Aim 1 : To determine the necessity of PU.1 for KLF4 gene expression by pulmonary macrophages and determine the role of KLF4 in the pathogenesis of acute lung inflammation and injury.
Specific Aim 2 : To determine the impact of PU.1 on epigenetic regulation of KLF4 gene expression and the relative role of KLF4 and KLF2 in regulating the resolution of neutrophilic lung inflammation and injury. Our studies are designed to interrogate whether targeting of the influence of PU.1 on KLF4 gene expression is an effective treatment for acute lung inflammation and injury and could possibly be applied to other acute and chronic inflammatory conditions such as type 1 diabetes, inflammatory bowel disease, psoriasis, and rheumatoid arthritis.

Public Health Relevance

The acute respiratory distress syndrome (ARDS) is a severe and life threatening condition that requires a mechanical breathing machine and other supportive care in an intensive care unit. We have shown that macrophages in the lung have an essential role in initiating the severe lung inflammation that causes ARDS. The purpose of this research is to define the basic molecular mechanisms that regulate macrophage involvement in ARDS in order to design new and effective treatments.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL075557-10
Application #
8722587
Study Section
Lung Injury, Repair, and Remodeling Study Section (LIRR)
Program Officer
Eu, Jerry Pc
Project Start
2003-12-15
Project End
2017-06-30
Budget Start
2014-07-01
Budget End
2015-06-30
Support Year
10
Fiscal Year
2014
Total Cost
Indirect Cost
Name
Ohio State University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
City
Columbus
State
OH
Country
United States
Zip Code
43210
Ackerman, Steven J; Park, Gye Young; Christman, John W et al. (2016) Polyunsaturated lysophosphatidic acid as a potential asthma biomarker. Biomark Med 10:123-35
Zhou, Qiyuan; Chen, Tianji; Zhang, Wei et al. (2016) Suppression of von Hippel-Lindau Protein in Fibroblasts Protects against Bleomycin-Induced Pulmonary Fibrosis. Am J Respir Cell Mol Biol 54:728-39
Nagre, Nagaraja; Wang, Shaohua; Kellett, Thomas et al. (2016) TRIM72 modulates caveolar endocytosis in repair of lung cells. Am J Physiol Lung Cell Mol Physiol 310:L452-64
Ballinger, Megan N; Christman, John W (2016) Pulmonary Macrophages: Overlooked and Underappreciated. Am J Respir Cell Mol Biol 54:1-2
Qian, Feng; Deng, Jing; Wang, Gang et al. (2016) Pivotal Role of Mitogen-Activated Protein Kinase-Activated Protein Kinase 2 in Inflammatory Pulmonary Diseases. Curr Protein Pept Sci 17:332-42
Chung, Sangwoon; Lee, Tae Jin; Reader, Brenda F et al. (2016) FoxO1 regulates allergic asthmatic inflammation through regulating polarization of the macrophage inflammatory phenotype. Oncotarget 7:17532-46
Ranjan, Ravi; Karpurapu, Manjula; Rani, Asha et al. (2016) Hemozoin Regulates iNOS Expression by Modulating the Transcription Factor NF-κB in Macrophages. Biochem Mol Biol J 2:
Ballinger, Megan N; Newstead, Michael W; Zeng, Xianying et al. (2015) IRAK-M promotes alternative macrophage activation and fibroproliferation in bleomycin-induced lung injury. J Immunol 194:1894-904
Baig, Mirza Saqib; Zaichick, Sofia V; Mao, Mao et al. (2015) NOS1-derived nitric oxide promotes NF-κB transcriptional activity through inhibition of suppressor of cytokine signaling-1. J Exp Med 212:1725-38
Ranjan, R; Lee, Y G; Karpurapu, M et al. (2015) p47phox and reactive oxygen species production modulate expression of microRNA-451 in macrophages. Free Radic Res 49:25-34

Showing the most recent 10 out of 50 publications